Department of Pulmonary and Critical Care, Hero DMC Heart Institute, Ludhiana, Punjab, India.
J Interv Cardiol. 2010 Oct;23(5):479-84. doi: 10.1111/j.1540-8183.2010.00580.x. Epub 2010 Sep 16.
Acute massive pulmonary embolism with failed systemic thrombolysis has a high morbidity and mortality with few treatment options available. This study assesses the role of combined modality of mechanical fragmentation and intralesional thrombolysis in failed systemic thrombolysis.
Seven (13.5%) of 52 patients with massive pulmonary embolism with persistent cardiogenic shock that failed systemic thrombolysis underwent imaging to confirm pulmonary embolism, and then mechanical fragmentation and intralesional thrombolysis. Mechanical breakdown of embolus was accomplished with 5-F multipurpose catheter to re-establish flow, followed by intralesional infusion of urokinase (4,400 IU/kg over 10 minutes followed by 4,400 IU/kg per hour over 24 hours).
Four (57.1%) of 7 were unsuccessfully thrombolyzed outside the hospital by urokinase, 2 (28.6%) with recombinant tissue-type plasminogen activator (rtPA) and 1 (14.3%) with streptokinase systemically before 24-48 hours of admission. At presentation, average heart rate and shock index were 121.7/min and 1.45, respectively. Average systolic pulmonary arterial pressure was 73 ± 2.65 mmHg at presentation, and postoperatively was significantly reduced to 39.7 ± 10.44 mmHg (P < 0.001). Mortality at 24 hours, 30 days, and 2 years follow-up was 0% (0/7).
Mechanical breakdown of thrombus followed by urokinase infusion may be a cost-effective, minimally invasive, and potentially life-saving procedure for the management of acute massive pulmonary embolism. Randomized controlled trials are required to compare this new strategy to contemporary conventional approaches.
溶栓治疗失败的急性大面积肺栓塞合并心源性休克发病率和死亡率高,治疗选择有限。本研究评估机械碎裂联合腔内溶栓治疗溶栓治疗失败的作用。
52 例大面积肺栓塞合并持续心源性休克患者中,有 7 例(13.5%)溶栓治疗失败,行影像学检查以确认肺栓塞,然后进行机械碎裂和腔内溶栓。用 5-F 多用途导管对栓子进行机械性破坏,以重新建立血流,然后向腔内注入尿激酶(10 分钟内注入 4400IU/kg,然后 24 小时内每小时注入 4400IU/kg)。
4 例(57.1%)在入院前 24-48 小时内曾在院外接受尿激酶、2 例(28.6%)接受重组组织型纤溶酶原激活剂(rtPA)、1 例(14.3%)接受链激酶全身溶栓治疗,但均未成功溶栓。就诊时,平均心率和休克指数分别为 121.7/min 和 1.45。就诊时平均收缩肺动脉压为 73±2.65mmHg,术后明显降至 39.7±10.44mmHg(P<0.001)。24 小时、30 天和 2 年随访时的死亡率为 0%(0/7)。
血栓机械性破坏后注入尿激酶可能是一种经济有效的微创治疗方法,对于急性大面积肺栓塞的治疗具有潜在的救生作用。需要进行随机对照试验,将这种新策略与当代常规方法进行比较。